Immuno-oncology clinical trials take a turn beyond PD1/PDL1 inhibitors.
Nat Rev Drug Discov
; 22(6): 442-443, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-37059846
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoplasms
Limits:
Humans
Language:
En
Journal:
Nat Rev Drug Discov
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2023
Document type:
Article